A DNA‑based test of the tumour can help two‑thirds of certain breast cancer patients safely avoid chemotherapy without significantly compromising their long-term outcomes

Karen Bonham was part of successful trial for genomic test that determines which women with breast cancer can safely avoid chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes